These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10762192)

  • 1. Intravenous infusion of 4-AP in chronic spinal cord injured subjects.
    Donovan WH; Halter JA; Graves DE; Blight AR; Calvillo O; McCann MT; Sherwood AM; Castillo T; Parsons KC; Strayer JR
    Spinal Cord; 2000 Jan; 38(1):7-15. PubMed ID: 10762192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal administration of 4-aminopyridine in chronic spinal injured patients.
    Halter JA; Blight AR; Donovan WH; Calvillo O
    Spinal Cord; 2000 Dec; 38(12):728-32. PubMed ID: 11175372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of 4-aminopyridine in patients with long-term spinal cord injury: a randomized, double-blind, placebo-controlled trial.
    Grijalva I; Guízar-Sahagún G; Castañeda-Hernández G; Mino D; Maldonado-Julián H; Vidal-Cantú G; Ibarra A; Serra O; Salgado-Ceballos H; Arenas-Hernández R
    Pharmacotherapy; 2003 Jul; 23(7):823-34. PubMed ID: 12885095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of 4-aminopyridine in humans with spinal cord injury: a long-term, controlled trial.
    Segal JL; Pathak MS; Hernandez JP; Himber PL; Brunnemann SR; Charter RS
    Pharmacotherapy; 1999 Jun; 19(6):713-23. PubMed ID: 10391417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients.
    Hansebout RR; Blight AR; Fawcett S; Reddy K
    J Neurotrauma; 1993; 10(1):1-18. PubMed ID: 8320728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases.
    Potter PJ; Hayes KC; Hsieh JT; Delaney GA; Segal JL
    Spinal Cord; 1998 Mar; 36(3):147-55. PubMed ID: 9554012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury.
    Potter PJ; Hayes KC; Segal JL; Hsieh JT; Brunnemann SR; Delaney GA; Tierney DS; Mason D
    J Neurotrauma; 1998 Oct; 15(10):837-49. PubMed ID: 9814639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial.
    Wolfe DL; Hayes KC; Hsieh JT; Potter PJ
    J Neurotrauma; 2001 Aug; 18(8):757-71. PubMed ID: 11526982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury.
    Hayes KC; Potter PJ; Wolfe DL; Hsieh JT; Delaney GA; Blight AR
    J Neurotrauma; 1994 Aug; 11(4):433-46. PubMed ID: 7837283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury.
    Hayes KC; Blight AR; Potter PJ; Allatt RD; Hsieh JT; Wolfe DL; Lam S; Hamilton JT
    Paraplegia; 1993 Apr; 31(4):216-24. PubMed ID: 8493036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury.
    van der Bruggen MA; Huisman HB; Beckerman H; Bertelsmann FW; Polman CH; Lankhorst GJ
    J Neurol; 2001 Aug; 248(8):665-71. PubMed ID: 11569894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid concentrations of 4-aminopyridine following intravenous injection and metered intrathecal delivery in canines.
    Pratt K; Toombs JP; Widmer WR; Borgens RB
    J Neurotrauma; 1995 Feb; 12(1):23-39. PubMed ID: 7783231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial.
    DeForge D; Nymark J; Lemaire E; Gardner S; Hunt M; Martel L; Curran D; Barbeau H
    Spinal Cord; 2004 Dec; 42(12):674-85. PubMed ID: 15356676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
    Lim JH; Muguet-Chanoit AC; Smith DT; Laber E; Olby NJ
    PLoS One; 2014; 9(12):e116139. PubMed ID: 25551385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humans.
    Segal JL; Brunnemann SR
    J Spinal Cord Med; 1998 Jul; 21(3):200-4. PubMed ID: 9863929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract Injury.
    Sindhurakar A; Mishra AM; Gupta D; Iaci JF; Parry TJ; Carmel JB
    Neurorehabil Neural Repair; 2017 Apr; 31(4):387-396. PubMed ID: 28107804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminopyridine improves pulmonary function in quadriplegic humans with longstanding spinal cord injury.
    Segal JL; Brunnemann SR
    Pharmacotherapy; 1997; 17(3):415-23. PubMed ID: 9165545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine.
    Rossini PM; Pasqualetti P; Pozzilli C; Grasso MG; Millefiorini E; Graceffa A; Carlesimo GA; Zibellini G; Caltagirone C
    Mult Scler; 2001 Dec; 7(6):354-8. PubMed ID: 11795455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 4-aminopyridine on cardiac repolarization, PR interval, and heart rate in patients with spinal cord injury.
    Isoda WC; Segal JL
    Pharmacotherapy; 2003 Feb; 23(2):133-6. PubMed ID: 12587799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.